The Best Psoriasis Medications Emerge
JAMA Dermatology · 01.01.2024 · 160 (1) · 99
DOI: 10.1001/jamadermatol.2023.4445 ↗Kurz gefasst
Metaanalyse in der Zeitschrift JAMA Dermatology, erschienen am 01.01.2024. Verfasst von Andrew Blauvelt und 1 weiteren Autor:innen. Beteiligte Einrichtung: Oregon Medical Research Center, Portland. Hauptthemen laut MEDLINE: Psoriasis. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 7 Literaturangaben.
Abstract (Originalsprache)
Clinical Question What are the most effective systemic medications to treat plaque psoriasis? Bottom Line The most effective drugs for psoriasis were infliximab, bimekizumab, ixekizumab, and risankizumab, and the clinical effectiveness was similar when these 4 drugs were compared against one another. No statistically significant differences in serious adverse events were identified in any of the drugs compared with placebo. The main limitations of this meta-analysis include the lack of assessment of clinical effectiveness beyond 52 weeks and the lack of safety assessments for nonserious adverse events.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Oregon Medical Research Center, Portland.
- Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Zitieren
APA
Blauvelt, A., & Noe, M. H. (2024). The Best Psoriasis Medications Emerge. JAMA Dermatology, 160(1), 99. https://doi.org/10.1001/jamadermatol.2023.4445
Vancouver
Blauvelt A, Noe MH. The Best Psoriasis Medications Emerge. JAMA Dermatology. 2024;160(1):99. doi:10.1001/jamadermatol.2023.4445
BibTeX
@article{Blauvelt2024,
author = {Blauvelt, Andrew and Noe, Megan H},
title = {The Best Psoriasis Medications Emerge},
journal = {JAMA Dermatology},
year = {2024},
volume = {160},
number = {1},
pages = {99},
doi = {10.1001/jamadermatol.2023.4445}
}
EUVIMED